Article content and detailed guides remain in English. The selected language applies to controls and quick instructions.
Back to articles Use cases
Email Prospecting Strategies for Biotech and Life Sciences Companies By Email Extractor Published October 8, 2026 7 min read
biotech life sciences industry guide email prospecting biopharma
On this page The Biotech and Life Sciences Landscape
Biotech is a research-intensive, capital-intensive industry where companies operate at different stages of drug development, each with distinct needs, budgets and decision-making structures:
Company stage
Examples
Characteristics
Typical headcount
Pre-clinical / seed
University spinouts, early startups
Small teams; funded by grants, angels, seed VC; focused on research
2-20
Clinical stage (Phase 1-2)
Series A-C funded biotechs
Building teams; running trials; high burn rate
20-200
Late clinical (Phase 3)
Pre-commercial biotechs
Preparing for launch; building commercial ops
100-500
Commercial stage
Revenue-generating biotechs
Marketing and selling approved products
200-5,000+
Large biopharma
Amgen, Gilead, Regeneron, Vertex, BioMarin
Multiple products; global operations
5,000-25,000+
Big pharma (with biotech focus)
Roche/Genentech, AbbVie, Bristol Myers Squibb
Large biotech divisions within pharma
25,000-100,000+
Contract research organisations (CROs)
IQVIA, Covance/LabCorp, PPD/Thermo Fisher, Syneos
Run clinical trials for biotech clients
10,000-80,000
CDMOs (contract development and manufacturing)
Catalent, Lonza, Samsung Biologics, WuXi Biologics
Manufacture drugs for biotech clients
5,000-30,000+
Life science tools
Thermo Fisher, Danaher, Agilent, Bio-Rad, Illumina
Sell instruments and reagents to researchers
10,000-80,000+
Diagnostics
Roche Diagnostics, Abbott, Hologic, Exact Sciences
Develop and sell diagnostic tests
5,000-50,000+
Digital health / health tech
Veeva Systems, Flatiron Health, Tempus, Benchling
Software for life sciences
500-5,000
Decision-making structure (clinical-stage biotech)
Role
What they decide
Prospecting notes
CEO / President
Strategic direction, partnerships, major vendors
Accessible in smaller biotechs; gatekept in larger ones
CSO (Chief Scientific Officer)
Research tools, lab equipment, CRO selection
Drives early-stage purchasing decisions
CMO (Chief Medical Officer)
Clinical trial design, CRO/site selection, regulatory strategy
Key for clinical-stage services
VP Clinical Operations
CRO management, trial logistics, clinical technology
Operational decisions for trials
VP Regulatory
Regulatory strategy, submission tools, eCTD publishing
Niche purchasing decisions
CFO / VP Finance
Financial systems, ERP, budgeting
Controls purse strings; critical for startups
VP Business Development
Partnerships, licensing, M&A
Not a buyer but a connector
VP Manufacturing / CMC
CDMO selection, process development, supply chain
Key for manufacturing decisions
VP Commercial (late stage)
Marketing, sales force, market access
Relevant when company approaches launch
Head of Data Science / Bioinformatics
Computational tools, data platforms, AI/ML
Growing role in modern biotech
VP Quality
QMS systems, compliance tools, validation
Quality and compliance software
Head of Procurement
Vendor management, lab supplies, services
Centralised purchasing in larger biotechs
Public databases
Source
What you find
Access
ClinicalTrials.gov
Trial sponsor contacts, principal investigators
clinicaltrials.gov (free)
SEC EDGAR
Public biotech officer information, proxy statements
sec.gov/edgar (free)
FDA Orange Book
Approved drug holders and patent information
fda.gov (free)
FDA Approval Letters
Company contacts on approval correspondence
fda.gov (free)
NIH Reporter
Grant recipients and principal investigators
reporter.nih.gov (free)
PubMed
Research authors and affiliations
pubmed.ncbi.nlm.nih.gov (free)
USPTO (Patent Office)
Patent inventors and assignees
patents.google.com (free)
EMA (European Medicines Agency)
European drug approvals with sponsor details
ema.europa.eu (free)
Crunchbase
Funding rounds, investors, executive teams
crunchbase.com (free tier + paid)
PitchBook
Detailed funding, board members, advisors
pitchbook.com (subscription)
Industry-specific directories
Source
What you find
Access
BioSpace
Biotech company profiles and job listings
biospace.com
Fierce Biotech
Industry news, executive moves
fiercebiotech.com
GEN (Genetic Engineering & Biotechnology News)
Company news, top company lists
genengnews.com
BIO (Biotechnology Innovation Organization)
Member directory
bio.org
PhRMA
Pharmaceutical company directory
phrma.org
ISPE (International Society for Pharmaceutical Engineering)
Pharmaceutical engineering professionals
ispe.org
DIA (Drug Information Association)
Regulatory and clinical professionals
diaglobal.org
AACR (American Association for Cancer Research)
Cancer researchers
aacr.org
Conference sources
Conference
Focus
Attendees
JP Morgan Healthcare Conference
Biotech CEO presentations, investor meetings
C-suite, investors, BD executives
BIO International Convention
Partnering, licensing, biotech networking
BD, C-suite, investors
ASCO (American Society of Clinical Oncology)
Oncology data presentations
Oncology researchers, pharma medical affairs
ASH (American Society of Hematology)
Hematology data
Hematologists, pharma medical affairs
AACR Annual Meeting
Cancer research
Cancer researchers, translational scientists
DIA Annual Meeting
Regulatory, clinical, pharmacovigilance
Regulatory, clinical ops, quality professionals
ISPE Annual Meeting
Pharmaceutical engineering and manufacturing
Manufacturing, quality, engineering
CPhI Worldwide
Pharmaceutical ingredients and manufacturing
Supply chain, manufacturing, procurement
Biotech Showcase
Early-stage biotech presentations
Startup CEOs, investors
SLAS (Society for Laboratory Automation and Screening)
Lab automation and screening
Lab directors, scientists, automation engineers
Email Patterns in Biotech
Biotech-specific prospecting challenges
Challenge
Why it happens
Workaround
Small teams with fluid roles
Early-stage biotechs have 10-50 people; titles may not match responsibilities
Target the CEO or CSO directly; they often make all vendor decisions
Grant-funded budgets
Academic spinouts operate on grant timelines
Understand the grant cycle and when funds are available
High turnover / short company lifespans
Many biotechs fail or get acquired
Monitor acquisition announcements; track where executives move
Regulatory sensitivity
FDA interactions are scrutinised; companies are cautious about vendor relationships
Do not reference regulatory outcomes in outreach
Data confidentiality
Clinical trial data is confidential until publication
Do not reference unpublished data you may have access to
Seasonal patterns
Conference season drives meetings; Q4 budget planning drives purchases
Time outreach to conference and budget cycles
Venture funding dependency
Pre-revenue biotechs spend VC money; purchasing follows funding rounds
Monitor funding announcements as triggers
Outreach Strategies by Company Stage
Pre-clinical and seed-stage biotechs
Approach
Details
Monitor NIH grant awards
New grants signal available budget for tools and services
Track university technology transfer
Newly licensed technologies create spinout companies
Reference their published research
"Your recent paper in Nature Biotechnology on..." shows domain knowledge
Offer founder-friendly pricing
Seed-stage companies are extremely budget-conscious
Target through incubators and accelerators
IndieBio, JLABS, BioLabs, Illumina Accelerator
Keep it short
Founders are wearing many hats; respect their time
Clinical-stage biotechs (Series A-C)
Approach
Details
Monitor funding rounds
Series A/B/C announcements signal hiring and vendor selection
Reference their pipeline
"As [Drug] moves into Phase 2..." shows you understand their stage
Target newly hired VPs
New VP hires signal budget for that function
Offer case studies from similar-stage companies
"We helped [similar biotech] during their Phase 2 programme..."
Time to IND filing or trial start
Companies need services and tools at specific development milestones
Reference ClinicalTrials.gov listings
Shows you understand their specific programme
Commercial and large biopharma
Approach
Details
Target by therapeutic area or franchise
Large biopharmas organise by therapeutic area
Reference their pipeline priorities
Quarterly earnings calls reveal pipeline priorities
Leverage peer references
"Three of the top 10 oncology biotechs use..."
Enter through innovation teams
Many large biopharmas have innovation or digital teams evaluating new technology
Target procurement for established categories
Procurement handles known vendor categories
Reference conference presentations
"Your poster at ASCO on [topic] highlighted..."
Compliance Considerations
Regulation
Application to biotech prospecting
CAN-SPAM / GDPR / CASL
Standard email compliance applies
Anti-Kickback Statute
Do not offer anything of value to induce purchasing decisions at companies receiving government funding
Sunshine Act (Open Payments)
Transfers of value to physicians must be reported; be aware of this when reaching medical affairs
FDA promotional regulations
Do not make claims about unapproved products or off-label uses
HIPAA
Do not reference patient data or protected health information
GxP (Good Practice regulations)
Understand which of your offerings fall under GxP validation requirements
21 CFR Part 11
If selling software to regulated companies, understand electronic records requirements
Metrics for Biotech Outreach
Metric
Typical range
Notes
Open rate (cold)
30-50%
Biotech professionals are information-hungry
Reply rate (cold)
3-8%
Higher when demonstrating scientific knowledge
Meeting booking rate
1-4%
Scientists appreciate substance over salesmanship
Sales cycle length
3-18 months
Shorter for tools; longer for services
Best send times
Tuesday-Thursday, 8:00-10:00 AM local time
Scientists start early; avoid Monday morning
Best months
January-March (new budgets); September-October (conference season)
Avoid late December and major conference weeks
When compiling contacts from ClinicalTrials.gov downloads (XML/HTML), PubMed exports (CSV), SEC filings (HTML/PDF) and conference materials (PDF), upload the files to Email Extractor to extract and deduplicate email addresses across sources.
Extract emails
